3AC fundamentals
An in-depth look to ACTINOGEN MEDICAL LTD. operating, investing, and financing activities
3AC free cash flow for H1 24 is -4 M EUR. For 2023, 3AC free cash flow was -5.33 M EUR and operating cash flow was -5.31 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM